Brief: Dogwood Therapeutics Reports Second Quarter 2025 Financial Results
13/08/2025 14:08
Aug 13 (Reuters) - Dogwood Therapeutics Inc DWTX.O: DOGWOOD THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS DOGWOOD THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.99 DOGWOOD THERAPEUTICS INC SAYS CASH ON HAND OF $13.4 MILLION PROVIDES OPERATIONAL RUNWAY THROUGH Q1 2026 Source text: ID:nGNX9Cr6S6 Further company coverage: DWTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study